JAMFX
Price
$6.67
Change
+$0.02 (+0.30%)
Updated
Dec 24 closing price
Net Assets
54.54M
SLMCX
Price
$159.67
Change
+$0.39 (+0.24%)
Updated
Dec 24 closing price
Net Assets
18.74B
Interact to see
Advertisement

JAMFX vs SLMCX

Header iconJAMFX vs SLMCX Comparison
Open Charts JAMFX vs SLMCXBanner chart's image
Jacob Internet I
Price$6.67
Change+$0.02 (+0.30%)
VolumeN/A
Net Assets54.54M
Columbia Seligman Tech & Info A
Price$159.67
Change+$0.39 (+0.24%)
VolumeN/A
Net Assets18.74B
JAMFX vs SLMCX Comparison Chart in %
View a ticker or compare two or three
VS
JAMFX vs. SLMCX commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAMFX is a Hold and SLMCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SLMCX has more cash in the bank: 18.7B vs. JAMFX (54.5M). JAMFX (0.00) and SLMCX (0.00) have matching dividends . JAMFX was incepted earlier than SLMCX: JAMFX (26 years) vs SLMCX (43 years). JAMFX (2.48) is less costly to investors than SLMCX (1.16). JAMFX is a more actively managed with annual turnover of: 58.00 vs. SLMCX (33.00). SLMCX has a lower initial minimum investment than JAMFX: SLMCX (2000) vs JAMFX (2500). SLMCX annual gain was more profitable for investors over the last year : 24.09 vs. JAMFX (8.28). SLMCX return over 5 years is better than : 54.29 vs. JAMFX (-24.20).
JAMFXSLMCXJAMFX / SLMCX
Total Expense Ratio2.481.16214%
Annual Report Gross Expense Ratio2.481.16214%
Fund Existence26 years43 years-
Gain YTD12.86028.34245%
Front LoadN/A6%-
Min. Initial Investment25002000125%
Min. Initial Investment IRAN/AN/A-
Net Assets54.5M18.7B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year8.2824.0934%
Returns for 3 years76.9296.4280%
Returns for 5 years-24.2054.29-45%
Returns for 10 years75.07188.4740%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNPHY10.370.20
+1.97%
Santen Pharmaceutical Co., Ltd.
GNGXF0.22N/A
N/A
Inventus Mining Corp.
HMTC3.60N/A
N/A
Homasote Co.
MPFRF4.38N/A
N/A
Mapfre SA
VDEVF35.66N/A
N/A
Van de Velde NV